For me, and again, this is subjective, it has a tangible effect in improving the recovery time from exercise
By reducing appetite and supporting sustained weight loss, GLP-1 therapy can improve insulin sensitivity over time
10.1111/acps.12711 Acta Psychiatr
Derived from the proglucagon gene, oxyntomodulin acts as a dual agonist at GLP-1 and glucagon receptors, promoting satiety and increasing energy expenditure (Cohen et al., 2003)
Does this mean that we have to resign ourselves to treating obesity for life, a bit like controlling hypertension, excess blood cholesterol or even insulin deficiency, with the help of drugs that should be administered continuously from the onset of pathologies